Press Room
+ News Categories + Corporate Categories Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer
04/30/2012
Erlotinib may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth.
Scientists find DNA variants linked with childhood kidney cancer
04/30/2012
A study published in Nature Genetics today, and funded by the Wellcome Trust and Cancer Research UK, reports on the first scan of common variants in the genomes of Wilms tumour patients.
Kidney Cancer Congress Builds Global Awareness
04/28/2012
International Kidney Cancer Congress invites collaboration with patients and organizations. Twitter: @IKCCongress
CDMRP programs help ensure funding for medical research
04/28/2012
The medical research programs within the CDMRP directly impact the health and lives of the U.S. military, their families and the public. Call your Congressman to urge support today!
US Cancer Care Costs Higher Than Europe, But Survival Longer
04/28/2012
The United States spends more on health care than any other country, but those high costs may be paying off in cancer survival, a new report suggests.
Herbal Remedies Linked to Kidney Failure and Cancer
04/28/2012
Aristolochic acid is recognized by the U.S. Department of Health and Human Services as a powerful nephrotoxin and human carcinogen associated with chronic kidney disease and UUC.
NIH Research Funding Faces An Unprecedented Threat
04/28/2012
Here's why your support of the American Kidney Cancer Alliance (AKCA.US) is more important than ever before: we must join together to help better explain and illustrate the value of cancer research and biomedical science to the economic health and well-being of the nation (as AACR asserts).
Systemic Therapy in Renal Cell Carcinoma: Advancing Paradigms
04/28/2012
This article will review the recent advances that form the current framework of therapy for RCC, as well as summarize key areas of progress and innovation in the evolving treatment paradigms for this disease.
'Firefly' allows partial kidney removal
04/28/2012
The Firefly works by identifying clear margins of kidney tumors and more accurately identifying critical vessels and tissue during surgery.
Cabozantinib to be Featured in Nine Presentations at ASCO
04/28/2012
"The nine data presentations at this year's ASCO Annual Meeting are indicative of the growing depth and breadth of cabozantinib's global clinical development program..."
News Feed| NeonCRM by Neon One |